AMERICAN CLINICAL LABORATORY ASSN for AMERICAN CLINICAL LABORATORY ASSN
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report (this page) | Jul 19, 2024 | $690,000 | Replaced |
| 2nd Quarter - Amendment | Nov 8, 2024 | $575,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, test coding and pricing, coverage, and payment, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); FDA and CMS policies related to diagnostics and laboratory regulation; FY 2024 budget and appropriations processes, extension of telehealth coverage policies, ordering of laboratory services pursuant to a telehealth visit, artificial intelligence in laboratory services; public-private sector testing response to Influenza A (H5) avian flu; H.R. 2377/S. 1000, Saving Access to Laboratory Services Act; H.R. 8818, American Privacy Rights Act of 2024; H.R. 8702/S. 4532, Improving Seniors Timely Access to Care Act; H.R. 7623, Telehealth Modernization Act of 2024; H.R. 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act; H.R. 2369 the Verifying Accurate Leading-edge IVCT Development Act (VALID Act) of 2023.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HOLLY GROSHOLZ | — |
| SUSAN VAN METER | — |
| MARY LEE WATTS New | — |
Medicare/Medicaid MMM
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, test coding and pricing, coverage, and payment, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); Saving Access to Laboratory Services Act H.R. 2377/S. 1000; H.R. 8702/S. 4532, Improving Seniors Timely Access to Care Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HOLLY GROSHOLZ | — |
| SUSAN VAN METER | — |
| MARY LEE WATTS New | — |
Health Issues HCR
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, test coding and pricing, coverage, and payment, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); FDA and CMS policies related to diagnostics and laboratory regulation; price transparency for clinical laboratory services; H.R. 2377/S. 1000, Saving Access to Laboratory Services Act; H.R. 8818, American Privacy Rights Act of 2024; Improving Seniors Timely Access to Care Act; H.R. 7623, Telehealth Modernization Act of 2024; H.R. 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act; H.R. 2369 the Verifying Accurate Leading-edge IVCT Development Act (VALID Act) of 2023.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HOLLY GROSHOLZ | — |
| SUSAN VAN METER | — |
| MARY LEE WATTS New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.